Clinical Trial

Efficacy of an EMDR App for PTSD and SUD

Recruiting
View on ClinicalTrials.gov →
Summary
The current proposal is aimed to confirm the efficacy of this novel therapeutic method (autonomous eye movement desensitization and reprocessing; A-EMDR) in a patient group (PTSD and SUD), and to assess the feasibility of the application within this group. While there is no basis to assume lower efficacy of the treatment with this population, confirming that hypothesis is an important and helpful step before a full-performance research study can be initiated. Furthermore, this study proposal will provide additional information regarding the feasibility for this population, which will allow for a more tailored approach in future study.
Protocol Amendment History 2 changes
notable Primary completion moved earlier: 2027-12-31 -> 2027-01-30 2026-05-23
minor Completion moved earlier: 2027-12-31 -> 2027-01-30 2026-05-23
Trial Details
NCT Number NCT07146633
Lead Sponsor Centre for Addiction and Mental Health
Conditions Posttraumatic Stress Disorder (PTSD), Substance Use Disorders
Enrollment 24 participants
Start Date 2026-01-20
Primary Completion 2027-01-30 (estimated)
Study Completion 2027-01-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-22